Literature DB >> 1655517

Tumor cell autocrine motility factor receptor.

I R Nabi1, H Watanabe, S Silletti, A Raz.   

Abstract

The ability to locomote and migrate is fundamental to the acquisition of invasive and metastatic properties by tumor cells. Autocrine motility factor (AMF) is a cytokine produced by various tumor cells which stimulates their in vitro motility and in vivo lung-colonizing ability. AMF stimulates cell motility via a receptor-mediated signalling pathway. Signal transduction following binding of AMF to its receptor, a cell surface glycoprotein of 78 kD (gp78), is mediated by a pertussis toxin sensitive G protein, inositol phosphate production and the phosphorylation of gp78. AMF induces gp78 internalization to intracellular tubulovesicles and transport to the leading edge stimulating pseudopodial protrusion and cell motility.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1655517     DOI: 10.1007/978-3-0348-7494-6_11

Source DB:  PubMed          Journal:  EXS        ISSN: 1023-294X


  10 in total

1.  The activity of a human endoplasmic reticulum-associated degradation E3, gp78, requires its Cue domain, RING finger, and an E2-binding site.

Authors:  Bo Chen; Jennifer Mariano; Yien Che Tsai; Anna H Chan; Mickael Cohen; Allan M Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-03       Impact factor: 11.205

Review 2.  E3 ubiquitin ligases in protein quality control mechanism.

Authors:  Deepak Chhangani; Ajay Prakash Joshi; Amit Mishra
Journal:  Mol Neurobiol       Date:  2012-05-19       Impact factor: 5.590

3.  The tumor autocrine motility factor receptor, gp78, is a ubiquitin protein ligase implicated in degradation from the endoplasmic reticulum.

Authors:  S Fang; M Ferrone; C Yang; J P Jensen; S Tiwari; A M Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-27       Impact factor: 11.205

Review 4.  Autocrine factors, type IV collagenase secretion and prostatic cancer cell invasion.

Authors:  M E Stearns; M Stearns
Journal:  Cancer Metastasis Rev       Date:  1993-03       Impact factor: 9.264

5.  Design, synthesis, and anticancer activity evaluation of irreversible allosteric inhibitors of the ubiquitin-conjugating enzyme Ube2g2.

Authors:  Chao Wang; Genbin Shi; Xinhua Ji
Journal:  Medchemcomm       Date:  2018-08-20       Impact factor: 3.597

6.  The crystal structure of a multifunctional protein: phosphoglucose isomerase/autocrine motility factor/neuroleukin.

Authors:  Y J Sun; C C Chou; W S Chen; R T Wu; M Meng; C D Hsiao
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

Review 7.  Viral and cellular MARCH ubiquitin ligases and cancer.

Authors:  Xiaoli Wang; Roger A Herr; Ted Hansen
Journal:  Semin Cancer Biol       Date:  2008-10-02       Impact factor: 15.707

8.  Expression of autocrine motility factor receptor correlates with disease progression in human gastric cancer.

Authors:  Y Hirono; S Fushida; Y Yonemura; H Yamamoto; H Watanabe; A Raz
Journal:  Br J Cancer       Date:  1996-12       Impact factor: 7.640

Review 9.  The Roles of the Ubiquitin-Proteasome System in the Endoplasmic Reticulum Stress Pathway.

Authors:  Junyan Qu; Tingting Zou; Zhenghong Lin
Journal:  Int J Mol Sci       Date:  2021-02-03       Impact factor: 5.923

Review 10.  Gp78 E3 Ubiquitin Ligase: Essential Functions and Contributions in Proteostasis.

Authors:  Vibhuti Joshi; Arun Upadhyay; Amit Kumar; Amit Mishra
Journal:  Front Cell Neurosci       Date:  2017-08-25       Impact factor: 5.505

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.